ADENTRA Inc. Logo

ADENTRA Inc.

ADEN.TO

(2.5)
Stock Price

38,77 CAD

5.19% ROA

8.09% ROE

16.15x PER

Market Cap.

775.849.466,61 CAD

83.92% DER

1.3% Yield

2.07% NPM

ADENTRA Inc. Stock Analysis

ADENTRA Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

ADENTRA Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.84x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Dividend Growth

The company has demonstrated exceptional dividend growth over the past five years, consistently increasing payouts to shareholders year after year.

3 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

4 ROE

The stock's ROE falls within an average range (12.26%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (7.27%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

6 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

7 Buffet Intrinsic Value

The company's stock seems undervalued (1.173) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

8 DER

The stock is burdened with a heavy load of debt (126%), making it financially unstable and potentially risky for investors.

9 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

11 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

ADENTRA Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

ADENTRA Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

ADENTRA Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

ADENTRA Inc. Revenue
Year Revenue Growth
2005 306.332.874
2006 311.022.649 1.51%
2007 335.014.642 7.16%
2008 210.600.657 -59.08%
2009 182.335.020 -15.5%
2010 197.623.380 7.74%
2011 225.287.952 12.28%
2012 307.677.693 26.78%
2013 348.633.977 11.75%
2014 392.548.627 11.19%
2015 411.906.117 4.7%
2016 587.248.716 29.86%
2017 824.684.691 28.79%
2018 832.776.811 0.97%
2019 897.150.665 7.18%
2020 976.592.741 8.13%
2021 1.616.199.000 39.57%
2022 2.579.568.000 37.35%
2023 2.234.692.000 -15.43%
2023 3.022.386.413 26.06%
2024 2.197.968.000 -37.51%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

ADENTRA Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 36.000 100%
2020 36.900 2.44%
2021 198.531 81.41%
2022 613.339 67.63%
2023 0 0%
2023 1.254.746 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

ADENTRA Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 7.091.087 100%
2012 8.794.467 19.37%
2013 8.389.605 -4.83%
2014 10.325.103 18.75%
2015 10.418.032 0.89%
2016 20.683.728 49.63%
2017 28.936.779 28.52%
2018 26.429.667 -9.49%
2019 29.809.304 11.34%
2020 37.070.642 19.59%
2021 60.589.000 38.82%
2022 84.675.000 28.45%
2023 133.520.000 36.58%
2023 99.605.000 -34.05%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

ADENTRA Inc. EBITDA
Year EBITDA Growth
2005 19.723.609
2006 17.572.923 -12.24%
2007 19.566.797 10.19%
2008 -127.963.024 115.29%
2009 -263.585 -48447.16%
2010 3.888.377 106.78%
2011 6.648.383 41.51%
2012 12.823.296 48.15%
2013 20.420.372 37.2%
2014 22.282.618 8.36%
2015 25.383.911 12.22%
2016 32.788.482 22.58%
2017 44.564.612 26.42%
2018 39.422.773 -13.04%
2019 58.823.214 32.98%
2020 70.765.237 16.88%
2021 185.450.000 61.84%
2022 262.892.000 29.46%
2023 140.068.000 -87.69%
2023 218.732.970 35.96%
2024 176.428.000 -23.98%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

ADENTRA Inc. Gross Profit
Year Gross Profit Growth
2005 57.161.185
2006 56.659.232 -0.89%
2007 63.351.510 10.56%
2008 37.876.746 -67.26%
2009 32.930.952 -15.02%
2010 34.351.504 4.14%
2011 39.784.524 13.66%
2012 54.089.643 26.45%
2013 63.502.916 14.82%
2014 67.852.282 6.41%
2015 71.797.736 5.5%
2016 106.969.719 32.88%
2017 152.584.493 29.89%
2018 147.241.985 -3.63%
2019 162.278.855 9.27%
2020 187.806.236 13.59%
2021 372.910.000 49.64%
2022 556.749.000 33.02%
2023 473.228.000 -17.65%
2023 591.392.338 19.98%
2024 476.872.000 -24.01%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

ADENTRA Inc. Net Profit
Year Net Profit Growth
2005 11.495.608
2006 3.120.281 -268.42%
2007 15.771.988 80.22%
2008 -29.780.608 152.96%
2009 -9.779.391 -204.52%
2010 955.847 1123.11%
2011 5.940.254 83.91%
2012 6.211.111 4.36%
2013 12.272.133 49.39%
2014 12.072.945 -1.65%
2015 14.517.651 16.84%
2016 17.753.143 18.22%
2017 23.820.278 25.47%
2018 23.611.080 -0.89%
2019 22.645.394 -4.26%
2020 28.034.000 19.22%
2021 103.145.000 72.82%
2022 128.668.000 19.84%
2023 32.344.000 -297.81%
2023 48.653.515 33.52%
2024 68.064.000 28.52%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

ADENTRA Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 1
2006 0 0%
2007 1 100%
2008 -2 150%
2009 -1 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 100%
2018 1 0%
2019 1 0%
2020 1 0%
2021 5 75%
2022 6 33.33%
2023 1 -500%
2023 2 50%
2024 4 50%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

ADENTRA Inc. Free Cashflow
Year Free Cashflow Growth
2005 10.035.301
2006 15.131.262 33.68%
2007 20.254.468 25.29%
2008 16.272.801 -24.47%
2009 9.695.348 -67.84%
2010 -3.475.444 378.97%
2011 2.114.593 264.36%
2012 -4.341.445 148.71%
2013 3.351.897 229.52%
2014 9.430.938 64.46%
2015 13.615.432 30.73%
2016 8.843.835 -53.95%
2017 12.181.311 27.4%
2018 -251.096 4951.26%
2019 68.286.800 100.37%
2020 61.746.760 -10.59%
2021 -72.884.000 184.72%
2022 199.875.000 136.46%
2023 56.473.000 -253.93%
2023 305.431.460 81.51%
2024 24.504.000 -1146.46%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

ADENTRA Inc. Operating Cashflow
Year Operating Cashflow Growth
2005 11.202.858
2006 15.905.113 29.56%
2007 20.831.061 23.65%
2008 16.622.021 -25.32%
2009 9.786.075 -69.85%
2010 -3.401.456 387.7%
2011 2.485.798 236.84%
2012 -3.489.038 171.25%
2013 4.238.474 182.32%
2014 10.729.114 60.5%
2015 14.948.583 28.23%
2016 10.915.854 -36.94%
2017 14.237.773 23.33%
2018 2.947.071 -383.12%
2019 71.045.036 95.85%
2020 64.193.512 -10.67%
2021 -65.418.000 198.13%
2022 210.685.000 131.05%
2023 59.126.000 -256.33%
2023 321.332.122 81.6%
2024 26.754.000 -1101.06%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

ADENTRA Inc. Capital Expenditure
Year Capital Expenditure Growth
2005 1.167.556
2006 773.850 -50.88%
2007 576.593 -34.21%
2008 349.219 -65.11%
2009 90.727 -284.92%
2010 73.988 -22.62%
2011 371.205 80.07%
2012 852.407 56.45%
2013 886.576 3.85%
2014 1.298.175 31.71%
2015 1.333.151 2.62%
2016 2.072.018 35.66%
2017 2.056.461 -0.76%
2018 3.198.167 35.7%
2019 2.758.235 -15.95%
2020 2.446.752 -12.73%
2021 7.466.000 67.23%
2022 10.810.000 30.93%
2023 2.653.000 -307.46%
2023 15.900.662 83.32%
2024 2.250.000 -606.7%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

ADENTRA Inc. Equity
Year Equity Growth
2005 134.617.702
2006 126.260.294 -6.62%
2007 137.394.728 8.1%
2008 67.257.189 -104.28%
2009 61.031.419 -10.2%
2010 63.972.764 4.6%
2011 70.420.176 9.16%
2012 76.407.024 7.84%
2013 85.166.749 10.29%
2014 93.455.713 8.87%
2015 103.011.479 9.28%
2016 168.141.507 38.74%
2017 189.921.272 11.47%
2018 209.930.765 9.53%
2019 216.988.065 3.25%
2020 239.457.009 9.38%
2021 414.032.000 42.16%
2022 506.972.000 18.33%
2023 694.726.826 27.03%
2023 522.918.000 -32.86%
2024 624.051.000 16.21%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

ADENTRA Inc. Assets
Year Assets Growth
2005 184.836.404
2006 170.216.197 -8.59%
2007 175.428.657 2.97%
2008 84.921.939 -106.58%
2009 70.929.233 -19.73%
2010 74.930.011 5.34%
2011 96.997.061 22.75%
2012 109.903.199 11.74%
2013 120.461.695 8.77%
2014 138.529.193 13.04%
2015 136.921.070 -1.17%
2016 276.077.672 50.4%
2017 296.543.141 6.9%
2018 326.541.999 9.19%
2019 436.334.754 25.16%
2020 459.515.668 5.04%
2021 1.114.924.000 58.79%
2022 1.428.974.000 21.98%
2023 1.652.011.965 13.5%
2023 1.289.545.000 -28.11%
2024 1.291.912.000 0.18%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

ADENTRA Inc. Liabilities
Year Liabilities Growth
2005 50.218.701
2006 43.955.902 -14.25%
2007 38.033.929 -15.57%
2008 17.664.749 -115.31%
2009 9.897.813 -78.47%
2010 10.957.246 9.67%
2011 26.576.885 58.77%
2012 33.496.175 20.66%
2013 35.294.946 5.1%
2014 45.073.480 21.69%
2015 33.909.590 -32.92%
2016 107.936.165 68.58%
2017 106.621.868 -1.23%
2018 116.611.234 8.57%
2019 219.346.689 46.84%
2020 220.058.659 0.32%
2021 700.892.000 68.6%
2022 922.002.000 23.98%
2023 957.285.139 3.69%
2023 766.627.000 -24.87%
2024 667.861.000 -14.79%

ADENTRA Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
92.59
Net Income per Share
1.92
Price to Earning Ratio
16.15x
Price To Sales Ratio
0.36x
POCF Ratio
4.87
PFCF Ratio
5.55
Price to Book Ratio
1.16
EV to Sales
0.6
EV Over EBITDA
7.88
EV to Operating CashFlow
8.69
EV to FreeCashFlow
9.22
Earnings Yield
0.06
FreeCashFlow Yield
0.18
Market Cap
0,78 Bil.
Enterprise Value
1,29 Bil.
Graham Number
34.01
Graham NetNet
-12.7

Income Statement Metrics

Net Income per Share
1.92
Income Quality
3.31
ROE
0.08
Return On Assets
0.03
Return On Capital Employed
0.09
Net Income per EBT
0.94
EBT Per Ebit
0.51
Ebit per Revenue
0.04
Effective Tax Rate
0.06

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.22
Operating Profit Margin
0.04
Pretax Profit Margin
0.02
Net Profit Margin
0.02

Dividends

Dividend Yield
0.01
Dividend Yield %
1.3
Payout Ratio
0.2
Dividend Per Share
0.55

Operating Metrics

Operating Cashflow per Share
6.36
Free CashFlow per Share
5.99
Capex to Operating CashFlow
0.06
Capex to Revenue
0
Capex to Depreciation
0.12
Return on Invested Capital
0.08
Return on Tangible Assets
0.05
Days Sales Outstanding
37.04
Days Payables Outstanding
29.96
Days of Inventory on Hand
80.22
Receivables Turnover
9.85
Payables Turnover
12.18
Inventory Turnover
4.55
Capex per Share
0.37

Balance Sheet

Cash per Share
0,93
Book Value per Share
26,77
Tangible Book Value per Share
8.32
Shareholders Equity per Share
26.77
Interest Debt per Share
24.33
Debt to Equity
0.84
Debt to Assets
0.41
Net Debt to EBITDA
3.13
Current Ratio
2.92
Tangible Asset Value
0,19 Bil.
Net Current Asset Value
-0,04 Bil.
Invested Capital
1049560000
Working Capital
0,41 Bil.
Intangibles to Total Assets
0.33
Average Receivables
0,22 Bil.
Average Payables
0,14 Bil.
Average Inventory
370990500
Debt to Market Cap
0.68

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

ADENTRA Inc. Dividends
Year Dividends Growth
2008 0
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 1 0%
2024 1 0%

ADENTRA Inc. Profile

About ADENTRA Inc.

ADENTRA Inc. engages in the wholesale distribution of architectural building products to the residential, repair and remodel, and commercial construction markets. It offers a range of decorative surfaces, including architectural grade plywood and veneers, hardwood lumber, laminates, acrylics, and composites for use in commercial and residential applications; specialty plywood and composite panel products for residential and commercial cabinet, countertop, store fixture, and RV and furniture industries; and other products comprising moldings, cabinet hardware, doors, millwork, adhesives, solid surface products, and decorative laminates. The company also manufactures, imports, and distributes hardwood lumber, millwork, and architectural sheet goods. It serves small-to-mid-sized industrial manufacturers of cabinets, moldings, custom finishing, home furniture, home renovations, finishing millwork for office buildings, restaurant and bar interiors, hotel lobbies, retail point-of-purchase displays, schools, hospitals, custom motor coaches, yacht interiors, and other specialty areas. As of March 11, 2022, the company operated 86 distribution facilities in North America. The company was formerly known as Hardwoods Distribution Inc. and changed its name to ADENTRA Inc. in December 2022. ADENTRA Inc. was incorporated in 2012 and is headquartered in Langley, Canada.

CEO
Mr. Robert J. Brown
Employee
2.828
Address
20161 86th Avenue
Langley, V2Y 2C1

ADENTRA Inc. Executives & BODs

ADENTRA Inc. Executives & BODs
# Name Age
1 Ian Tharp
Investor Relations
70
2 Mr. David Hughes
Senior Vice President of Acquisitions
70
3 Mr. Jeffrey William Leys
President of ProDealer & Home Center
70
4 Ms. Renee Murdoch
Vice President of Human Resources
70
5 Mr. Lance R. Blanco
Senior Vice President of Corporate Development
70
6 Mr. Robert J. Brown
President, Chief Executive Officer & Director
70
7 Mr. Faiz H. Karmally
Vice President, Chief Financial Officer & Secretary
70
8 Mr. Drew H. Dickinson
President of US Industrial
70

ADENTRA Inc. Competitors